Oncology and Hematology
Episodes 1-16 of 91
Jason Hafron, MD
Carissa Chu. MD
- CME/CE
Optimal Sequencing of ADCs in Endocrine Refractory HR+/HER2- Metastatic Breast Cancer
0.50 creditsJavier Cortes, MD, PhD
Komal Jhaveri, MD, FACP
- Oncology and Hematology
SunRISe-1: TAR-200 in BCG-Unresponsive High-Risk Bladder Cancer
- Oncology and Hematology
Real-World Sequencing and Survival in Locally Advanced Prostate Cancer
- Oncology and Hematology
Updates from Apa-RP: Apalutamide and ADT in High-Risk Localized Prostate Cancer
- Oncology and Hematology
Evolving Trends in Germline Genetic Testing for Prostate Cancer
Jeffrey V. Matous, MD
Donna Catamero, NP
Ajai Chari, MD
Susana Campos, MD, MPH
- MinuteCE®
ADCs on the Horizon for Breast Cancer: Managing Treatment-Emergent Toxicities
1.00 program creditNadia Harbeck, MD, PhD
Nadia Harbeck, MD, PhD
- Prev
- Next